The effect of BIM deletion polymorphism on intrinsic resistance and clinical outcome of cancer patient with kinase inhibitor therapy

A common deletion polymorphism within B-cell chronic lymphocytic leukemia-lymphoma like 11 gene (BIM) was deemed to be a genetic cause leading to compromised kinase inhibitor therapeutic efficacy in cancer individuals. However, the results reported were not consistent. Thus, a comprehensive meta-ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying, Hou-Qun, Chen, Jie, He, Bang-Shun, Pan, Yu-Qin, Wang, Feng, Deng, Qi-Wen, Sun, Hui-Ling, Liu, Xian, Wang, Shu-Kui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466895/
https://www.ncbi.nlm.nih.gov/pubmed/26076815
http://dx.doi.org/10.1038/srep11348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466895/
https://www.ncbi.nlm.nih.gov/pubmed/26076815
http://dx.doi.org/10.1038/srep11348

Ejemplares similares